Rebalbusa, Felomina G.
HRN: 18-78-10 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2024
CEFTRIAXONE 1G (VIAL)
05/09/2024
05/15/2024
IVT
1g
Q12
UTI
Waiting Final Action